Vincerx Pharma, Inc. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d4591e41-6910-4e30-9f53-1180a28000c4/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-30.1M | 2024-01-01 – 2024-12-31 | evidence 0001193125-25-065487 |
| FY 2023 | $-40.2M | 2023-01-01 – 2023-12-31 | evidence 0001193125-24-081994 |
| FY 2022 | $-63.0M | 2022-01-01 – 2022-12-31 | evidence 0001193125-24-081994 |
| FY 2021 | $-39.3M | 2021-01-01 – 2021-12-31 | evidence 0001193125-22-087454 |
| FY 2020 | $-16.6M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-161167 |
| FY 2019 | $-45.0k | 2019-03-01 – 2019-12-31 | evidence 0001193125-21-089563 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).